LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Lexaria Bioscience Corp.
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026
$2.60−0.26 (-9.09%)
Close on Oct 19, 2026
- Market cap
- $64.50M
- P/E (TTM)
- –
- Dividend yield
- –
Lexaria Bioscience Corp. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IP Licensing [Member] | $696.00K | $457.99K | $146.80K | $54.56K | $334.97K | $232.91K | $198.00K | – | – | 98.6% | +52.0% |
| Consumer Products | – | – | – | – | – | $151.63K | $24.61K | – | – | – | – |
| Corporate | – | $0 | $0 | $32.60K | $90.49K | $0 | $0 | – | – | – | – |
| Consolidated Total [Member] | – | – | – | – | $722.74K | $384.54K | – | – | – | – | – |
| R & D | – | – | – | $54.80K | – | – | – | – | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IP Licensing [Member] | $696.00K | $457.99K | – | – | – | – | – | – | – | 98.6% | +52.0% |
| B2B [Member] | $9.92K | $5.39K | – | – | – | – | – | – | – | 1.4% | +84.2% |
| Other [Member] | $0 | $900 | – | – | – | – | – | – | – | 0.0% | -100.0% |
| Products | – | – | – | $113.44K | $297.28K | $150.99K | $24.28K | $16.97K | $16.87K | – | – |
| License Revenue [Member] | – | – | – | – | – | $232.91K | $198.00K | $415.18K | $45.81K | – | – |
| Freight revenue | – | – | – | – | – | – | – | $1.14K | $964 | – | – |
| Freight revenue | – | – | – | – | – | $641 | $328 | $1.14K | – | – | – |
| B2B [Member] | – | – | – | – | $297.28K | $151.63K | – | – | – | – | – |
| R&D [Member] | – | $900 | $35.24K | $54.80K | – | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Lexaria Bioscience's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.